However, the direct vascular protective effects of GLP-1 RAs, including anti-inflammatory and endothelial actions, could theoretically operate independently of baseline metabolic status [31]
GLP-1 medications can be HSA eligible, but whether yours qualifies depends entirely on one thing: the medical diagnosis behind your prescription
Who is a good candidate
Tirzepatide (Mounjaro and Zepbound), semaglutide-based medications such as Wegovy, and other GLP-1based treatments require medical evaluation to determine eligibility, appropriate dosing, and safety
In 2014, the Food and Drug Administration (FDA) first approved the use of GLP-1s for weight loss, and the results have been nothing short of transformative for many patients
Ozempic and Wegovy both have semaglutide, the active ingredient